FINAL-2023-Viral-Response-Transition-Dolutegravir-with-cover-rev (1) Viral Response with Transition to Dolutegravir-Based Treatment, 2018–2020, Homa Bay, Kenya › FINAL-2023-Viral-Response-Transition-Dolutegravir-with-cover-rev (1) Report